Search

everythinglearnresearchcommunity

for

Search:↓

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Abrocitinib may effectively treat stubborn alopecia universalis.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

The laser comb did not improve hair regrowth in mice with alopecia areata.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

PUVASOL might effectively treat complete scalp baldness.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

CD2 might be a new treatment target for patchy alopecia areata.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.